Our malaria vaccine candidate VLPM01 clinical trial designed to evaluate the safety, tolerability, immunogenicity and experimental efficacy of VLPM01 in healthy, malaria-naïve adult volunteers. The study will be conducted at the Walter Reed Army Institute of Research in Silver Spring, Maryland (WRAIR), as this institute has extensive experience in conducting clinical studies of malaria vaccines with Controlled Human Malaria Infection (CHMI). A total of 36 participants will be enrolled in this study.
For more information (ClinicalTrials.gov)
Contact the WRAIR Clinical Trials Center Recruitment Office Phone: 1-866-4-CTC-STUDY (866-428-2788).